Global Fish Oil EPA and DHA Market Growth 2025-2031

The global Fish Oil EPA and DHA market size is predicted to grow from US$ 1620 million in 2025 to US$ 1991 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Fish oil is a kind of oil extracted from fatty fish. It is rich in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and various n-3 polyunsaturated fatty acids (n-3PUFA), which are essential unsaturated fatty acids for the human body. EPA can clean up blood vessel waste, soften blood vessels and improve immunity, and is known as the "blood vessel scavenger"; DHA is often used for pregnant women and infants. By taking DHA, it can promote the normal growth and development of the brain, thus playing a so-called brain-boosting and intelligence-enhancing effect, commonly known as "brain gold".

Rising Burden of Chronic Diseases Fuels Preventive Nutrition: As cardiovascular diseases, diabetes, neurodegenerative disorders, and systemic inflammation become global public health challenges, demand for preventive and functional nutrition is rising. EPA is well-known for its anti-inflammatory and triglyceride-lowering effects, while DHA supports neural and retinal development. These health benefits position EPA and DHA as essential components of daily supplementation, increasingly recommended by healthcare professionals.

Growing Focus on Cognitive and Brain Health Accelerates DHA Demand: With aging populations and heightened awareness of childhood cognitive development, DHA is gaining traction as a key structural component of the brain and nervous system. DHA supplementation is now routine in prenatal supplements, infant formula, and cognitive support products for aging adults, making it a central growth driver in the omega-3 category.

Expanding Middle Class and Health-Conscious Consumers Boost Uptake: In emerging markets, especially in Asia-Pacific, the expanding middle class and rising health literacy are driving the shift from curative medicine to preventive self-care. Fish oil supplements are increasingly viewed as affordable and accessible wellness investments by families looking to maintain long-term health.

Pharmaceutical-Grade EPA Adoption Reinforces Clinical Value: Prescription EPA products like icosapent ethyl have demonstrated strong clinical benefits in reducing cardiovascular risk. As more regulatory bodies and health systems embrace these results, the pharmaceutical segment is emerging as a high-value growth pillar, pushing the omega-3 industry further into the healthcare domain.

Advancements in Purification Technology Improve Quality and Appeal: Historically, concerns over fishy taste, oxidation, and contamination hindered broader omega-3 adoption. Today, molecular distillation, supercritical CO₂ extraction, and re-esterification techniques have led to purer, better-tasting, and more bioavailable products, greatly enhancing consumer trust and satisfaction.

LP Information, Inc. (LPI) ' newest research report, the “Fish Oil EPA and DHA Industry Forecast” looks at past sales and reviews total world Fish Oil EPA and DHA sales in 2024, providing a comprehensive analysis by region and market sector of projected Fish Oil EPA and DHA sales for 2025 through 2031. With Fish Oil EPA and DHA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fish Oil EPA and DHA industry.

This Insight Report provides a comprehensive analysis of the global Fish Oil EPA and DHA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fish Oil EPA and DHA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fish Oil EPA and DHA market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fish Oil EPA and DHA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fish Oil EPA and DHA.

This report presents a comprehensive overview, market shares, and growth opportunities of Fish Oil EPA and DHA market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Fish Oil EPA
Fish Oil DHA

Segmentation by Application:
Dietary Supplements
Fortified Foods and Beverages
Infant Formula
Pharmaceuticals
Pet Foods
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
KD Pharma
Croda
BASF
Yuwang Pharma
GC Rieber VivoMega
Pelagia (EPAX)
Golden Omega
TASA
KinOmega Biopharm
Omega Protein
Huatai Phrama
AlaskOmega (Wiley Companies)
Jiangsu Auqi Marine Biotechnology
Sinomega Biotech Engineering
Xinzhou Marine Biological Products
Nu-Mega (Clover)
Skuny Bioscience
Renpu Pharmaceuticals
Polaris
Solutex

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fish Oil EPA and DHA market?

What factors are driving Fish Oil EPA and DHA market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fish Oil EPA and DHA market opportunities vary by end market size?

How does Fish Oil EPA and DHA break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.